John Fowler
2018
In 2018, John Fowler earned a total compensation of $1.8M as Chief Executive Officer at Kezar Life Sciences, a 125% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $248,400 |
|---|---|
| Option Awards | $1,080,542 |
| Salary | $460,000 |
| Other | $11,601 |
| Total | $1,800,543 |
Fowler received $1.1M in option awards, accounting for 60% of the total pay in 2018.
Fowler also received $248.4K in non-equity incentive plan, $460K in salary and $11.6K in other compensation.
Rankings
In 2018, John Fowler's compensation ranked 6,259th out of 14,244 executives tracked by ExecPay. In other words, Fowler earned more than 56.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,259 out of 14,244 | 56th |
Division Manufacturing | 2,397 out of 5,765 | 58th |
Major group Chemicals And Allied Products | 896 out of 2,128 | 58th |
Industry group Drugs | 752 out of 1,817 | 59th |
Industry Pharmaceutical Preparations | 584 out of 1,391 | 58th |
Source: SEC filing on April 30, 2019.
Fowler's colleagues
We found two more compensation records of executives who worked with John Fowler at Kezar Life Sciences in 2018.